ADMA Biologics Inc.

10/04/2021 | Press release | Distributed by Public on 10/04/2021 05:03

ADMA Biologics Announces the Presentation of Real-World Experience in the Management of Respiratory Syncytial Virus (RSV) Presented at IDWeek 2021